- Home
- » Tags
- » Vorsetuzumab mafodotin
Top View
- Safety of Medicines
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- IMSN Open Letter on Antibody-Drug Conjugate 2151012
- A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
- Ek DGÖ ARMONİZE SİSTEM KOMİTESİNİN 47. DÖNEM
- Antibody-Drug Conjugate/ADC Related
- Gm, Ke, Lr, Ls, Mw, Mz, Na, Rw, Sd, Sl, St, Sz, Tz, Ug, Zm, Zw
- "The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- WO 2015/038782 Al 19 March 2015 (19.03.2015) P O P C T
- (INN) for Biological and Biotechnological Substances
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2013.1
- Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy
- WO 2015/038818 A2 19 March 2015 (19.03.2015) P O P C T